Zinc lozenge Forte with vitamin C and Echinacea
Zinc lozenge Forte with vitamin C and Echinacea, NPN 80088525: natural health product licensed in Canada. Medicinal ingredients: Zinc, Vitamine C, Echinacea purpurea, Astragalus membranaceus.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc dihydraté | 15 milligramme | Not calculated |
| Vitamine C Source : Acide ascorbique | 60 milligramme | Not calculated |
| Echinacea purpurea Source : Herbe(s) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 50 milligramme | 12.5 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 25 milligramme | 6.25 milligramme | Not calculated |
Non-medicinal ingredients
Saveur de menthe poivrée, Sorbitol, Jus de framboise déshydraté, D-Fructose, Saveur de fruits des champs, Acide stéarique, Poudre d'écorce d'orme rouge, Stéarate de magnésium, Menthol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Pastille | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Contribue au maintien d'une bonne santé. Aide au maintien des fonctions immunitaires. Source d'antioxydants qui aident à protéger contre (les effets oxydatifs causés par les radicaux libres. Aider à soulager les symptômes et réduire la durée des infections des voies respiratoires supérieures. Thérapie de soutien pour traiter les infections des voies respiratoires supérieures.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si les symptômes persistent ou s'aggravent, consulter un praticien de soins de santé. Si vous souffrez d'une maladie systémique progressive telle que la tuberculose, la collagénose, la sclérose en plaques, le SIDA et/ou une infection au VIH, consulter un praticien de soins de santé avant d'en faire l'usage. Si vous avez une maladie auto-immune, consulter un praticien de soins de santé avant d'en faire l'usage. Si vous prenez des immunosuppresseurs, consulter un praticien de soins de santé avant l'usage. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez.
- Effets indésirables connus
Des cas rares de réactions allergiques sévères peuvent se manifester; faire preuve de prudence si vous êtes allergique aux plante de la famille des Astéracées/Composées/Marguerites.
Product record
- Other names
- Zinc lozenge Forte avec Echinacea, Zinc lozenge Forte with vitamin C, Echinacea and berry
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80088525
- Status
- Inactive licence
- Licence date
- 1 October 2018
- Revision date
- 17 March 2021
- Form
- Pastille
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80088525
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Echinacea purpurea
Read the warning, when it applies and the studies cited
ECHINACEA - ECHINACEA PURPUREA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015: European Medicines Agency (GB). EMA/HMPC/48704/2014. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. Final. [Accessed 2024 December 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Condition of application: Preparations containing herb top.
Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).
Sources cited by Health Canada (5)
- EMA 2015: European Medicines Agency (GB). EMA/HMPC/48704/2014. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. Final. [Accessed 2024 December 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
- Kligler B. 2003. Echinacea. American Family Physician 67(1):77-80. [Accessed 2024 February 22]. Available from: http://www.aafp.org/afp/2003/0101/p77.html
- MHRA 2018: Medicines and Healthcare products Regulatory Agency (GB). Press release: Echinacea herbal products should not be used in children under 12 years old. [Accessed 2024 December 11]. Available from: https://webarchive.nationalarchives.gov.uk/ukgwa/20140208035927/http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON180627
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé; 1999.
- Astragalus membranaceus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Zinc lozenge Forte with vitamin C and Echinacea (BIOVANTEK): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80088525-zinc-lozenge-forte-with-vitamin-c-and-echinacea, updated 17 March 2021.